BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17687644)

  • 21. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of hepatic progesterone and estrogen receptors in the female turtle, Chrysemys picta: relationship to vitellogenesis.
    Custodia-Lora N; Novillo A; Callard IP
    Gen Comp Endocrinol; 2004 Apr; 136(2):232-40. PubMed ID: 15028527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone but not estradiol 17beta potentiates local GH secretions by hormone-dependent breast cancer explants. An in vitro study.
    Milewicz T; Gregoraszczuk EL; Augustowska K; Krzysiek J; Sztefko K; Ryś J
    Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):127-32. PubMed ID: 15772906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The growth inhibitory activity of the Cimicifuga racemosa extract Ze 450 is mediated through estrogen and progesterone receptors-independent pathways.
    Garita-Hernandez M; Calzado MA; Caballero FJ; Macho A; Muñoz E; Meier B; Brattström A; Fiebich BL; Appel K
    Planta Med; 2006 Mar; 72(4):317-23. PubMed ID: 16557472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxylated polychlorinated biphenyl metabolites are anti-estrogenic in a stably transfected human breast adenocarcinoma (MCF7) cell line.
    Kramer VJ; Helferich WG; Bergman A; Klasson-Wehler E; Giesy JP
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):363-76. PubMed ID: 9194421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.
    Yu Y; Zhou Q; Hang Y; Bu X; Jia W
    Cancer; 2007 Jun; 109(11):2374-82. PubMed ID: 17464948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
    Laplante Y; Cadot C; Fournier MA; Poirier D
    Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.
    Lim YC; Desta Z; Flockhart DA; Skaar TC
    Cancer Chemother Pharmacol; 2005 May; 55(5):471-8. PubMed ID: 15685451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of gonadal steroids on progesterone receptor, estrogen receptor, and vitellogenin expression in male turtles (Chrysemys picta).
    Custodia-Lora N; Novillo A; Callard IP
    J Exp Zool A Comp Exp Biol; 2004 Jan; 301(1):15-25. PubMed ID: 14695685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer.
    Curran EM; Judy BM; Duru NA; Wang HQ; Vergara LA; Lubahn DB; Estes DM
    Clin Cancer Res; 2006 Oct; 12(19):5641-7. PubMed ID: 17000652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA.
    Lin VC; Ng EH; Aw SE; Tan MG; Ng EH; Chan VS; Ho GH
    Clin Cancer Res; 1999 Feb; 5(2):395-403. PubMed ID: 10037189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice.
    Ju YH; Doerge DR; Helferich WG
    Food Chem Toxicol; 2008 Jan; 46(1):310-20. PubMed ID: 17919800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
    Harrell JC; Dye WW; Allred DC; Jedlicka P; Spoelstra NS; Sartorius CA; Horwitz KB
    Cancer Res; 2006 Sep; 66(18):9308-15. PubMed ID: 16982776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro.
    Connor K; Howell J; Chen I; Liu H; Berhane K; Sciarretta C; Safe S; Zacharewski T
    Fundam Appl Toxicol; 1996 Mar; 30(1):93-101. PubMed ID: 8812239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ratio of concentrations of estrogen receptors to progesterone receptors (ER/PR) in the cytosol of breast cancers (stratification by forming of groups differing in PR).
    Hochmann J
    Neoplasma; 2007; 54(4):290-6. PubMed ID: 17822318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogenic activities of sesame lignans and their metabolites on human breast cancer cells.
    Pianjing P; Thiantanawat A; Rangkadilok N; Watcharasit P; Mahidol C; Satayavivad J
    J Agric Food Chem; 2011 Jan; 59(1):212-21. PubMed ID: 21141889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
    Jeng MH; Langan-Fahey SM; Jordan VC
    Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signaling.
    Scherbakov AM; Lobanova YS; Shatskaya VA; Krasil'nikov MA
    Steroids; 2009 Jun; 74(6):535-42. PubMed ID: 19428442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.